CD274 and cancer: Predictive biomarkers play a crucial role in cancer therapy by guiding treatment selection and improving patient outcomes, with examples including BRCA mutations for PARP inhibitors and PD‐L1 expression for immune checkpoint inhibitors, which help identify patients likely to benefit from these therapies.